Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 4/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5606937 | 0.87 | CA1 (0.45) | CA1CA2CA7USP2ALDH1A1 | |
| SCHEMBL28611328 | 0.87 | — | — | |
| SCHEMBL44830 | 0.87 | — | — | |
| SCHEMBL19540573 | 0.82 | USP2 (0.44) | CA1CA2CA7USP2ALDH1A1 | |
| SCHEMBL13909999 | 0.81 | USP2 (0.47) | CA1CA2CA7USP2ALDH1A1 | |
| SCHEMBL23615815 | 0.79 | USP2 (0.50) | CA1CA2CA7USP2ALDH1A1 | |
| SCHEMBL8754223 | 0.78 | CA1 (0.63) | CA1CA2CA7USP2ALDH1A1 | |
| Propene SCHEMBL247056 | 0.78 | USP2 (0.47) | CA1CA2CA7USP2THRB | |
| SCHEMBL3263381 | 0.78 | USP2 (0.53) | CA1CA2CA7USP2ALDH1A1 | |
| SCHEMBL31243387 | 0.78 | HSD17B10 (0.43) | CA1CA2CA7USP2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2229134-B1 | CONCENTRATED PERSONAL CLEANSING COMPOSITIONS | PROCTER & GAMBLE (US) | 2017-11-15 | — | — | EP | claimed |
| EP-2203150-B1 | PERSONAL CARE COMPOSITIONS COMPRISING UNDECYL SULFATES | PROCTER & GAMBLE (US) | 2016-06-01 | — | — | EP | claimed |
| EP-2203150-A2 | PERSONAL CARE COMPOSITIONS COMPRISING UNDECYL SULFATES | The Procter & Gamble Company (US) | 2010-07-07 | — | — | EP | claimed |
| US-20090155383-A1 | Personal Care Compositions Comprising Undecyl Sulfates | THE PROCTER & GAMBLE COMPANY | 2009-06-18 | — | — | US | claimed |
| WO-2009053931-A2 | PERSONAL CARE COMPOSITIONS COMPRISING UNDECYL SULFATES | THE PROCTER & GAMBLE COMPANY (US) | 2009-04-30 | — | — | WO | claimed |
| US-11932448-B2 | Bottle adapted for storing a liquid composition with an aesthetic design suspended therein | THE PROCTER & GAMBLE COMPANY (US) | 2024-03-19 | — | — | US | disclosed |
| US-11896689-B2 | Method of making a clear personal care comprising microcapsules | THE PROCTER & GAMBLE COMPANY (US) | 2024-02-13 | — | — | US | disclosed |
| EP-4291149-A1 | CONTAINER CONTAINING A SHAMPOO COMPOSITION WITH AN AESTHETIC DESIGN FORMED BY BUBBLES | The Procter & Gamble Company (US) | 2023-12-20 | — | — | EP | disclosed |
| EP-4291155-A1 | MULTI-PHASE SHAMPOO COMPOSITION WITH AN AESTHETIC DESIGN | The Procter & Gamble Company (US) | 2023-12-20 | — | — | EP | disclosed |
| US-20230210730-A1 | CLEAR CLEANSING COMPOSITION | PROCTER & GAMBLE (US) | 2023-07-06 | — | — | US | disclosed |
| US-11628126-B2 | Clear cleansing composition | THE PROCTER & GAMBLE COMPANY (US) | 2023-04-18 | — | — | US | disclosed |
| EP-4103335-A1 | BOTTLE ADAPTED FOR STORING A LIQUID COMPOSITION WITH AN AESTHETIC DESIGN SUSPENDED THEREIN | The Procter & Gamble Company (US) | 2022-12-21 | — | — | EP | disclosed |
| US-8653014-B2 | Shampoo composition containing a gel network | THE PROCTER & GAMBLE COMPANY (US) | 2014-02-18 | — | — | US | disclosed |
| US-8440605-B2 | Process for making a cleaning composition employing direct incorporation of concentrated surfactants | THE PROCTER & GAMBLE COMPANY (US) | 2013-05-14 | — | — | US | disclosed |
| US-20130090279-A1 | Shampoo Composition Containing a Gel Network | THE PROCTER & GAMBLE COMPANY (US) | 2013-04-11 | — | — | US | disclosed |
| EP-2440646-B1 | PROCESS FOR MAKING A CLEANING COMPOSITION EMPLOYING DIRECT INCORPORATION OF CONCENTRATED SURFACTANTS | PROCTER & GAMBLE (US) | 2013-03-06 | — | — | EP | disclosed |
| US-20110048449-A1 | Multiple Product System For Hair | THE PROCTER & GAMBLE COMPANY | 2011-03-03 | — | — | US | disclosed |
| US-20110053826-A1 | Process For Making A Cleaning Composition Employing Direct Incorporation Of Concentrated Surfactants | THE PROCTER & GAMBLE COMPANY | 2011-03-03 | — | — | US | disclosed |
| US-20090221463-A1 | Concentrated Personal Cleansing Compositions | THE PROCTER & GAMBLE COMPANY | 2009-09-03 | — | — | US | disclosed |
| US-20090155383-A1 | Personal Care Compositions Comprising Undecyl Sulfates | THE PROCTER & GAMBLE COMPANY | 2009-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130090279-A1 | Shampoo Composition Containing a Gel Network | DEGS1, SGMS2, S100P | CA1 3716/4885CA2 2815/4885CA7 3161/4885 |
| US-20090155383-A1 | Personal Care Compositions Comprising Undecyl Sulfates | USP25, UTS2R, USP30 | CA1 4862/4885CA2 4769/4885CA7 2613/4885 |
| US-20090221463-A1 | Concentrated Personal Cleansing Compositions | CUTA, UNG, MSH2 | CA1 2836/4885CA2 2279/4885CA7 452/4885 |
| US-20230210730-A1 | CLEAR CLEANSING COMPOSITION | LIPC, ABHD16A, SGMS2 | CA1 1025/4885CA2 2744/4885CA7 1934/4885 |
| US-11896689-B2 | Method of making a clear personal care comprising microcapsules | AQP1, IL33, AQP3 | CA1 2470/4885CA2 3186/4885CA7 1631/4885 |
| US-11628126-B2 | Clear cleansing composition | LIPC, ABHD16A, SGMS2 | CA1 1025/4885CA2 2744/4885CA7 1934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.